Alderley Lighthouse Labs is a UKAS ISO:15189 accredited pathology services provider based in Alderley Park. Founded in 2022, the company is headquartered in the United Kingdom. It recently secured a significant £1.04M Venture Round investment on August 14, 2023, with backing from Seneca Partners and NPIF Maven Equity Finance.
This investment signifies a strong show of support from well-established institutions in the healthcare and biotech sectors. It underscores the industry's recognition of Alderley Lighthouse Labs' innovative approach to pathology services and its potential for growth and impact. This injection of capital is likely to fuel the company's expansion, drive further research and development, and position it for heightened success in the competitive landscape of healthcare and biotech startups.| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | Unknown | 1 |
|
27 Jun 2024 |
| Seed Round | £1.04M | 2 |
|
14 Aug 2023 |
| Seed Round | £500.00K | 1 |
|
22 Nov 2022 |
No recent news or press coverage available for Alderley Lighthouse Labs.
We care about your data, and we'd love to use cookies make your experience better.
